nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse
|
Raffaghello, L. |
|
2003 |
197 |
1-2 |
p. 205-209 5 p. |
artikel |
2 |
Apoptosis pathways in neuroblastoma therapy
|
Fulda, Simone |
|
2003 |
197 |
1-2 |
p. 131-135 5 p. |
artikel |
3 |
Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells
|
De Preter, Katleen |
|
2003 |
197 |
1-2 |
p. 53-61 9 p. |
artikel |
4 |
A role for distinct cell types in determining malignancy in human neuroblastoma cell lines and tumors
|
Ross, Robert A. |
|
2003 |
197 |
1-2 |
p. 35-39 5 p. |
artikel |
5 |
Author Index
|
|
|
2003 |
197 |
1-2 |
p. 239-240 2 p. |
artikel |
6 |
Biological and clinical role of p73 in neuroblastoma
|
Romani, M. |
|
2003 |
197 |
1-2 |
p. 111-117 7 p. |
artikel |
7 |
Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany
|
Schilling, Freimut H |
|
2003 |
197 |
1-2 |
p. 19-28 10 p. |
artikel |
8 |
der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) – detected by spectral karyotyping (SKY)
|
Stark, Batia |
|
2003 |
197 |
1-2 |
p. 75-79 5 p. |
artikel |
9 |
Development of Fab′ fragments of anti-GD2 immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma
|
Brignole, Chiara |
|
2003 |
197 |
1-2 |
p. 199-204 6 p. |
artikel |
10 |
Disseminated tumor cells in the bone marrow – chances and consequences of microscopical detection methods
|
Ambrosa, Peter F. |
|
2003 |
197 |
1-2 |
p. 29-34 6 p. |
artikel |
11 |
Editorial Board
|
|
|
2003 |
197 |
1-2 |
p. ii- 1 p. |
artikel |
12 |
Evolving significance of prognostic markers associated with new treatment strategies in neuroblastoma
|
Mora, Jaume |
|
2003 |
197 |
1-2 |
p. 119-124 6 p. |
artikel |
13 |
Familial neuroblastoma: a complex heritable disease
|
Tonini, Gian Paolo |
|
2003 |
197 |
1-2 |
p. 41-45 5 p. |
artikel |
14 |
Fenretinide as an anti-angiogenic agent in neuroblastoma
|
Ribatti, Domenico |
|
2003 |
197 |
1-2 |
p. 181-184 4 p. |
artikel |
15 |
Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?
|
Scott, Debbie |
|
2003 |
197 |
1-2 |
p. 81-86 6 p. |
artikel |
16 |
Genetic and epigenetic alterations in neuroblastoma
|
Tonini, Gian Paolo |
|
2003 |
197 |
1-2 |
p. 69-73 5 p. |
artikel |
17 |
Hypoxia-induced dedifferentiation in neuroblastoma cells
|
Jögi, Annika |
|
2003 |
197 |
1-2 |
p. 145-150 6 p. |
artikel |
18 |
Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma
|
Raffaghello, L. |
|
2003 |
197 |
1-2 |
p. 151-155 5 p. |
artikel |
19 |
Induction of GADD153 and Bak: novel molecular targets of fenretinide-induced apoptosis of neuroblastoma
|
Lovat, Penny E. |
|
2003 |
197 |
1-2 |
p. 157-163 7 p. |
artikel |
20 |
Instructions to Authors
|
|
|
2003 |
197 |
1-2 |
p. 257-259 3 p. |
artikel |
21 |
Long-term results and risk profiles of patients in five consecutive trials (1979–1997) with stage 4 neuroblastoma over 1 year of age
|
Berthold, F |
|
2003 |
197 |
1-2 |
p. 11-17 7 p. |
artikel |
22 |
Negative autoregulation of p73 and p53 by ΔNp73 in regulating differentiation and survival of human neuroblastoma cells
|
Nakagawa, Takahito |
|
2003 |
197 |
1-2 |
p. 105-109 5 p. |
artikel |
23 |
Neuroblastoma – a developmental perspective
|
McConville, Carmel M |
|
2003 |
197 |
1-2 |
p. 3-9 7 p. |
artikel |
24 |
Neuroblastoma – developmental and molecular biology meet therapy design
|
Schwab, Manfred |
|
2003 |
197 |
1-2 |
p. 1- 1 p. |
artikel |
25 |
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylase
|
Jikai, J. |
|
2003 |
197 |
1-2 |
p. 219-224 6 p. |
artikel |
26 |
Neuroblastoma oligo-capping cDNA project: toward the understanding of the genesis and biology of neuroblastoma
|
Ohira, Miki |
|
2003 |
197 |
1-2 |
p. 63-68 6 p. |
artikel |
27 |
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma
|
Lange, B |
|
2003 |
197 |
1-2 |
p. 225-230 6 p. |
artikel |
28 |
Recombinant antibodies in the immunotherapy of neuroblastoma: perspectives of new developments
|
Bestagno, Marco |
|
2003 |
197 |
1-2 |
p. 193-198 6 p. |
artikel |
29 |
Retinoid therapy of high-risk neuroblastoma
|
Reynolds, C.Patrick |
|
2003 |
197 |
1-2 |
p. 185-192 8 p. |
artikel |
30 |
Subject Index
|
|
|
2003 |
197 |
1-2 |
p. 241-255 15 p. |
artikel |
31 |
Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment
|
Brignole, Chiara |
|
2003 |
197 |
1-2 |
p. 231-235 5 p. |
artikel |
32 |
Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma
|
Yang, Xuezhong |
|
2003 |
197 |
1-2 |
p. 137-143 7 p. |
artikel |
33 |
The MYCN oncoprotein as a drug development target
|
Lu, Xiaohong |
|
2003 |
197 |
1-2 |
p. 125-130 6 p. |
artikel |
34 |
The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis
|
van Noesel, Max M. |
|
2003 |
197 |
1-2 |
p. 165-172 8 p. |
artikel |
35 |
The p53 pathway and its inactivation in neuroblastoma
|
Tweddle, Deborah A. |
|
2003 |
197 |
1-2 |
p. 93-98 6 p. |
artikel |
36 |
The regulation of angiogenesis in neuroblastoma
|
Chlenski, Alexandre |
|
2003 |
197 |
1-2 |
p. 47-52 6 p. |
artikel |
37 |
The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification
|
Hogarty, Michael D. |
|
2003 |
197 |
1-2 |
p. 173-179 7 p. |
artikel |
38 |
The role of the MEIS homeobox genes in neuroblastoma
|
Geerts, Dirk |
|
2003 |
197 |
1-2 |
p. 87-92 6 p. |
artikel |
39 |
Vaccination with minigenes encoding for novel ‘self’ antigens are effective in DNA-vaccination against neuroblastoma
|
Huebener, N. |
|
2003 |
197 |
1-2 |
p. 211-217 7 p. |
artikel |
40 |
Volume Contents
|
|
|
2003 |
197 |
1-2 |
p. 237-238 2 p. |
artikel |
41 |
When p53 needs p73 to be functional – forced p73 expression induces nuclear accumulation of endogenous p53 protein
|
Goldschneider, David |
|
2003 |
197 |
1-2 |
p. 99-103 5 p. |
artikel |